Several studies have shown that GLP-1 agonists can improve menstrual cyclicity, reduce hyperandrogenism, and increase ovulation rates in women with PCOS
Scientists have documented consequences for public health and the economy
Frysak Z, Schovanek J, Iacobone M, Karasek D (2015) Insulin-like growth factors in a clinical setting: review of IGF-I
While recent randomized clinical trials have rightly generated a lot of interest in GLP-1 agonists, having these results, specifically reduction in the composite outcome of heart failure hospitalizations and all-cause mortality, replicated in a large cohort study will likely increase their utilization even before we see a change in guidelines, she told Healthline
If you choose to drink occasionally while on semaglutide, eat a small, low-fat, low-FODMAP meal first
The clinic is cash-pay only, with no in-network billing for compounded products and no brand-name option to route through insurance